Eesti -
eesti -
Ravimiamet
chantico kõvakapsel
g.l. pharma gmbh - fingolimood - kõvakapsel - 0,5mg 10tk; 0,5mg 28tk; 0,5mg 60tk; 0,5mg 30tk; 0,5mg 98tk; 0,5mg 7tk
Eesti -
eesti -
Ravimiamet
cortico veyxin süstesuspensioon
veyx-pharma gmbh - prednisoloon - süstesuspensioon - 8,95mg 1ml 100ml 6tk
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - ravimid hingamisteede obstruktiivsete haiguste, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
Eesti -
eesti -
Ravimiamet
spiriva inhalatsioonipulber kõvakapslis
boehringer ingelheim international gmbh - tiotroopium - inhalatsioonipulber kõvakapslis - 18mcg 90tk; 18mcg 300tk; 18mcg 10tk; 18mcg 60tk; 18mcg 150tk
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - ravimid hingamisteede obstruktiivsete haiguste, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - ravimid hingamisteede obstruktiivsete haiguste, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
